Sir Christopher Chope raises questions on vaccine damage payment scheme

Christopher Chope: To ask the Secretary of State for Health and Social Care, how many applications there have been to the Vaccine Damage Payment Scheme relating to covid-19 vaccinations; and how many claims have been (a) awarded, (b) rejected and (c) were unresolved for more than six months.

Christopher Chope: To ask the Secretary of State for Health and Social Care, of the claims to the Vaccine Damage Payment Scheme relating to covid-19 vaccinations, how many claims made before 6 September 2023 failed because (a) causation was accepted but disablement was assessed at less than 60%, (b) there was a lack of causation and (c) any other reason.

Hormone treatment in those undergoing transgender transitioning is associated with an increased risk of blood clots.

"There has been recent publicity showing that the use of hormone treatment in those undergoing transgender transitioning is associated with an increased risk of blood clots.

We want to reassure women taking transdermal HRT to treat menopausal symptoms, that there are no increased risks of blood clots to them."

- Dr Louise Newson, Founder, The Menopause Charity and Prof Beverley Hunt, Founder, Thrombosis UK

Award for the Expert Haematology Panel (EHP)

The EHP were pivotal in describing the new condition, vaccine-induced immune thrombocytopenia and thrombosis (VITT), improving survival of patients and preventing further cases, enabling the COVID-19 vaccine programme to continue safely.

Page 1 of 16 Next